RxSight, Inc. RXST Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$46.64M-75.7% | -$38.94M-41.8% | -$35.73M-16.4% | -$32.25M+12.3% | -$26.55M+40.3% | ||
| $3.32M+2.7% | $3.27M-8.6% | $2.93M-28.7% | $3.21M-21.0% | $3.24M-23.6% | ||
| $32.42M+19.7% | $31.61M+28.3% | $31.08M+42.7% | $29.52M+53.0% | $27.08M+57.9% | ||
| -$8.52M-187% | -$6.66M-166% | -$1.19M-111% | $2.72M-78.1% | $9.78M+10.1% | ||
| $13.26M+155% | $11.48M+130% | $8.67M— | $7.11M— | $5.2M— | ||
| -$22K— | $627K— | -$1.46M— | -$1.33M— | —— | ||
| —— | —— | —— | —— | $3.44M+66.6% | ||
| —— | —— | -$33K-106% | $112K-81.1% | $1.5M+337% | ||
| —— | —— | $8K-89.2% | $16K-85.8% | $33K-77.4% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$17.57M-2.6% | -$15.51M+11.8% | -$18.66M+13.8% | -$17.47M+41.0% | -$17.12M+48.3% | ||
| $4.01M-0.8% | $3.83M-29.6% | $3.54M-42.8% | $4.06M-29.2% | $4.05M-32.9% | ||
| $301.1M-8.1% | $239.28M-29.0% | $193.64M-40.9% | $202.37M-37.3% | $327.68M+54.2% | ||
| $310M+35.4% | $260M+7.0% | $225M-5.5% | $234M-9.7% | $229M-14.9% | ||
| —— | —— | —— | $26.25M— | -$104.05M— | ||
| $3.4M-70.1% | $3.95M-81.0% | $5.88M-72.5% | $9.59M-51.0% | $11.36M-39.8% | ||
| —— | —— | $47K-43.4% | $39K-64.2% | $47K-66.2% | ||
| —— | $0— | $0— | -$80K— | —— | ||
| —— | —— | —— | $5.18M— | $114.59M— | ||
| —— | —— | —— | $15K+1,600% | $0-100% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $72K— | $29K— | ||
| $7.96M-19.5% | $8.52M-5.1% | $9.31M+17.5% | $9.94M+47.3% | $9.88M+55.1% | ||
| —— | —— | —— | —— | $3.44M+66.6% | ||
| —— | —— | -$33K-106% | $112K-81.1% | $1.5M+337% | ||
| $1.96M+505% | $1.93M+378% | $1.39M+187% | $1.49M+368% | $324K+21.8% | ||
| —— | —— | $8K-89.2% | $16K-85.8% | $33K-77.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $66K— | $55K— | ||
| $301.1M-8.1% | $239.28M-29.0% | $193.64M-40.9% | $202.37M-37.3% | $327.68M+54.2% | ||
| $310M+35.4% | $260M+7.0% | $225M-5.5% | $234M-9.7% | $229M-14.9% | ||
| —— | —— | $47K-43.4% | $39K-64.2% | $47K-66.2% | ||
| -$1.12M— | -$2.06M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $566K— | —— | ||
| $2.91M+26.7% | $2.63M+22.0% | $2.46M+12.9% | $2.41M+7.7% | $2.3M+3.7% | ||
| —— | $0— | $0— | $0— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $72K— | $29K— | ||
| -$21.58M-5.2% | -$19.34M+13.6% | -$22.2M+18.3% | -$20.88M+40.9% | -$20.52M+47.6% | ||
| -$21.58M-5.2% | -$19.34M+13.6% | -$22.2M+18.3% | -$20.88M+40.9% | -$20.52M+47.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does RxSight, Inc. generate?
- RxSight, Inc. (RXST) generated -$17.6M in operating cash flow over the trailing twelve months.
- What is RxSight, Inc.'s free cash flow?
- After $4.0M of capital expenditures, RxSight, Inc.'s free cash flow was -$21.6M over the trailing twelve months, down 5.2% year over year.
- Where does RxSight, Inc.'s cash flow data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
